Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Domperidone prices in Germany, the highest-cost reporting region, rose 8.0% in H1 2026, climbing from USD 82.4/KG in Q1 to USD 89.0/KG by Q2 as spring gastrointestinal disorder and nausea management pharmaceutical procurement and firmer synthesis intermediate costs drove consistent buying. Globally, the average rose from USD 58.0/KG in Q1 to USD 62.6/KG in Q2, an 8.0% gain. For H2 2026, a global average of USD 63.50-70.00/KG is expected, with continued firming on Middle East supply disruptions and growing gastrointestinal and antiemetic pharmaceutical sector demand.
Domperidone is a selective dopamine D2 and D3 receptor antagonist prokinetic and antiemetic produced through a multi-step chemical synthesis from benzimidazolone and piperidine-derived intermediates. Unlike metoclopramide, domperidone does not readily cross the blood-brain barrier, limiting central nervous system side effects and making it a preferred antiemetic agent in many international markets. The largest pull comes from pharmaceutical formulations for the management of nausea and vomiting associated with gastroenteritis, cancer chemotherapy, radiotherapy, dopaminergic medication side effects in Parkinson’s disease management, and postoperative recovery. Additional demand comes from gastrointestinal motility disorder management in gastroparesis, functional dyspepsia, and gastro-oesophageal reflux disease where the prokinetic action accelerates gastric emptying and improves lower oesophageal sphincter tone. Off-label galactagogue use to increase prolactin levels and promote breast milk production in lactating mothers represents a significant demand segment in certain emerging market and Asian pharmaceutical markets. Benzimidazolone and piperidine synthesis intermediate costs, gastrointestinal and antiemetic pharmaceutical sector demand, and regional API production capacity all feed into the price.
The balance of supply and demand for domperidone through H2 2026 leans moderately firm. Synthesis intermediate and benzimidazolone precursor costs firmed from Middle East chemical supply chain disruptions. Gastrointestinal motility disorder and antiemetic pharmaceutical demand is growing with expanding access to gastroenterology specialist treatment and growing chemotherapy patient populations.
The main upside risk is a sustained synthesis intermediate cost increase alongside accelerating gastrointestinal and oncology antiemetic demand in emerging markets. The main downside risk is continued Chinese domperidone API production surplus and competitive generic pharmaceutical pricing that limits the global price recovery.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 63.50 - 70.00 | Synthesis cost firming and GI/antiemetic demand support |
| United States | 67.50 - 74.00 | Steady GI and antiemetic demand holds it firm |
| China | 48.00 - 54.50 | Large API capacity keeps it the most affordable |
| Germany | 89.50 - 96.00 | High synthesis and energy costs keep it the most expensive |
| India | 65.50 - 72.00 | Growing GI and antiemetic demand holds a firm middle |
US domperidone prices averaged USD 72.4/KG in Q2 2026, up 7.9% from USD 67.1/KG in Q1 2026. Firmer synthesis intermediate costs and recovering gastrointestinal and oncology antiemetic procurement drove consistent buying through the quarter.
Why did the price of Domperidone change in Q2 2026 in the United States?
Firmer benzimidazolone and piperidine synthesis intermediate costs raised the API production cost floor. Gastrointestinal motility disorder and oncology antiemetic procurement lifted buying from API suppliers. Parkinson’s disease dopaminergic medication nausea management and off-label lactation support demand provided additional consistent buying support.
Chinese domperidone prices averaged USD 50.4/KG in Q2 2026, up 7.9% from USD 46.7/KG in Q1 2026, the lowest among the tracked markets. Spring pharmaceutical formulation export and domestic gastrointestinal demand lifted buying. Firmer domestic synthesis intermediate costs raised the production floor despite large domestic API capacity.
Why did the price of Domperidone change in Q2 2026 in China?
Spring gastrointestinal pharmaceutical export and domestic antiemetic demand lifted buying from domestic API producers. Firmer domestic synthesis intermediate costs raised the production cost floor. Large domestic domperidone API capacity kept China the most affordable source.
German domperidone prices averaged USD 89.0/KG in Q2 2026, up 8.0% from USD 82.4/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Consistent gastrointestinal, Parkinson’s management, and oncology antiemetic demand maintained consistent buying.
Why did the price of Domperidone change in Q2 2026 in Germany?
Higher benzimidazolone synthesis intermediate and energy costs elevated European API production economics. Middle East supply disruptions added import cost premiums to precursor supply chains. Consistent gastrointestinal motility, Parkinson’s management, and oncology antiemetic demand maintained consistent procurement.
Indian domperidone prices averaged USD 68.8/KG in Q2 2026, up 7.8% from USD 63.8/KG in Q1 2026. Growing gastrointestinal and antiemetic pharmaceutical demand supported buying. Firmer import-linked synthesis intermediate costs raised the production floor through the quarter.
Why did the price of Domperidone change in Q2 2026 in India?
Growing gastrointestinal motility disorder and antiemetic formulation demand lifted procurement from domestic API and formulation producers. Firmer import-linked synthesis intermediate costs raised the production floor. Export demand from Southeast Asian and African markets provided additional buying support near USD 68.8/KG.
US domperidone prices averaged USD 67.1/KG in Q1 2026, declining modestly on the quarter. Post-holiday gastrointestinal procurement moderation and soft synthesis costs reduced buying urgency near USD 67.1/KG.
Why did the price of Domperidone change in Q1 2026 in the United States?
Post-holiday gastrointestinal and antiemetic procurement moderation reduced buying urgency. Soft synthesis intermediate costs eased the production cost floor. The market eased to USD 67.1/KG before the Q2 spring pharmaceutical season recovery.
Chinese prices averaged USD 46.7/KG in Q1 2026, declining on the quarter. Post-Lunar New Year gastrointestinal export and domestic demand moderation held the market near USD 46.7/KG.
Why did the price of Domperidone change in Q1 2026 in China?
Post-Lunar New Year gastrointestinal and antiemetic procurement moderation reduced buying urgency. Soft synthesis intermediate costs maintained comfortable production economics. Large domestic API capacity maintained adequate supply near USD 46.7/KG.
German prices averaged USD 82.4/KG in Q1 2026, declining on the quarter. Post-holiday gastrointestinal and pharmaceutical procurement moderation and soft synthesis costs eased the market near USD 82.4/KG.
Why did the price of Domperidone change in Q1 2026 in Germany?
Post-holiday gastrointestinal and antiemetic procurement moderation reduced buying urgency. Soft synthesis intermediate costs eased the European production floor. The market eased to USD 82.4/KG before the Q2 spring gastrointestinal season surge.
Indian prices averaged USD 63.8/KG in Q1 2026, declining modestly on the quarter. Post-holiday gastrointestinal and antiemetic demand moderation and soft import costs held the market near USD 63.8/KG.
Why did the price of Domperidone change in Q1 2026 in India?
Post-holiday gastrointestinal and antiemetic procurement moderation reduced buying urgency. Soft import-linked synthesis intermediate costs eased the production floor. The market eased to USD 63.8/KG before the Q2 demand season recovery.
Global domperidone prices showed a volatile alternating pattern through 2025 and H1 2026, with a Q3 2025 dip, a Q4 year-end pharmaceutical procurement uptick, a Q1 2026 post-holiday dip, and a strong Q2 2026 spring gastrointestinal season surge. The average eased from USD 58.0/KG in Q2 2025 to USD 57.4/KG in Q3, recovered to USD 58.6/KG in Q4, eased to USD 58.0/KG in Q1 2026, then surged to USD 62.6/KG in Q2 2026, a net gain of about 8.0% over the window. Synthesis intermediate cycles and gastrointestinal and antiemetic pharmaceutical demand patterns drove the alternating quarterly oscillation.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 62.6 | +8.0% | ↑ Rising |
| Q1 2026 | 58.0 | -1.0% | ↓ Falling |
| Q4 2025 | 58.6 | +2.1% | ↑ Rising |
| Q3 2025 | 57.4 | -1.0% | ↓ Falling |
| Q2 2025 | 58.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Domperidone prices showed a broadly stable alternating pattern through 2025. The global average opened at USD 57.8/KG in Q1 2025 and closed near USD 58.6/KG in Q4, a marginal full-year gain of about 1.4%. Gastrointestinal and antiemetic pharmaceutical demand season cycles and synthesis intermediate cost dynamics created the characteristic quarterly oscillation throughout the year.
US prices fell from about USD 68.5/KG in Q1 2025 to USD 67.8/KG by Q4, a decline of 1.0%. Alternating gastrointestinal and antiemetic procurement cycles and adequate synthesis supply maintained modest downward pressure through the year.
Chinese prices firmed from roughly USD 46.0/KG in Q1 2025 to USD 47.2/KG by Q4, a gain of 2.6%. Growing domestic and export gastrointestinal and antiemetic demand drove the modest firming. China held the lowest price level throughout the year.
German prices fell from about USD 84.0/KG in Q1 2025 to USD 83.2/KG by Q4, a decline of 1.0%. Post-holiday gastrointestinal and pharmaceutical demand moderation and adequate synthesis supply maintained modest downward pressure.
Indian prices firmed from roughly USD 63.5/KG in Q1 2025 to USD 64.5/KG by Q4, a gain of 1.6%. Growing domestic gastrointestinal and antiemetic formulation demand and export activity drove the modest firming through the year.
Expert Market Research: Your Source for Real-Time Domperidone Price Intelligence
Expert Market Research tracks domperidone prices continuously across every major producing and consuming region. The team traces causation through benzimidazolone and piperidine synthesis intermediate economics, gastrointestinal and antiemetic pharmaceutical sector demand cycles, and regional API production capacity. Contact Expert Market Research today for domperidone pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Pharmaceutical formulations for nausea and vomiting management in gastroenteritis, chemotherapy, and Parkinson’s disease dopaminergic medication side effects take the largest share. Gastroparesis and functional dyspepsia prokinetic therapy, gastro-oesophageal reflux management, and off-label galactagogue use in lactating mothers also consume significant volumes globally.
The Q2 2026 average was USD 72.4/KG in the United States, USD 50.4/KG in China, USD 89.0/KG in Germany, and USD 68.8/KG in India. Germany remains the highest-priced market.
The global average rose from USD 58.0/KG in Q1 to about USD 62.6/KG in Q2, a gain of around 8.0%. Spring gastrointestinal and antiemetic season demand and firmer synthesis intermediate costs drove the H1 2026 surge.
Gastrointestinal disorder and nausea management pharmaceutical procurement season cycles created alternating quarterly buying patterns. Post-holiday procurement moderation created Q1 and Q3 dips while spring and year-end pharmaceutical procurement upticks created Q2 and Q4 surges throughout the period.
The global average is expected in the USD 63.50 to 70.00/KG range for H2 2026, with continued firming as synthesis intermediate costs stay elevated and gastrointestinal and oncology antiemetic demand grows.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on gastrointestinal and antiemetic demand, and China prices lowest on large domestic API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to benzimidazolone and piperidine synthesis intermediate costs, gastrointestinal disorder and chemotherapy-related antiemetic demand cycles, and Chinese API production discipline. Middle East chemical supply events and oncology treatment expansion are key signals.
Asia Pacific leads with China and India holding the largest domperidone API synthesis capacity, followed by Europe. Any synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time gastrointestinal and antiemetic formulation contracts around seasonal demand cycles, build cover when synthesis intermediate signals tightening, and monitor Chinese API production output as the primary supply signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.